Stephen Mandel
Lone Pine Capital
Stephen Mandel Tenet Healthcare Corp stake
total: 304
Lone Pine Capital THC trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Held since:
- 2025 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Stephen Mandel doesn't hold any Tenet Healthcare Corp (THC) shares. To date, the estimated cost basis is nearly $196.63 for "buy" trades and estimated average "sell" price is $188.71. Lone Pine Capital first purchased THC in 2025 Q4, initially acquiring about 1.79M shares. Since the initial investment in Tenet Healthcare Corp (THC), Lone Pine Capital has made 2 more transactions.
When did Stephen Mandel sell Tenet Healthcare Corp (THC)?
Stephen Mandel sold off the entire Tenet Healthcare Corp (THC) position in 2026 Q2.
When did Stephen Mandel buy Tenet Healthcare Corp (THC)?
Stephen Mandel first invested in Tenet Healthcare Corp (THC) in 2025 Q4 at the reported quarter-end price of $198.72 per share.
What's the cost basis of Lone Pine Capital's THC stake?
The estimated cost basis for Tenet Healthcare Corp (THC) stake is around $196.63 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $196.63
- Weighted AVG sell price:
- $188.71
Stephen Mandel's historical trades in Tenet Healthcare Corp
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
0
|
$188.71
|
|
-100% (-2,258,717)
|
-3.4%
|
|
2026 Q1
|
3.40%
|
2,258,717
|
$188.71
|
$426,242,485
|
+26.37% (+471,391)
|
+0.71%
|
|
2025 Q4
|
2.61%
|
1,787,326
|
$198.72
|
$355,177,423
|
new
|
+2.61%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.